Glofitamab with Polatuzumab Vedotin in Refractory Burkitt's Lymphoma. Prica A, Roschewski M, Beale P, Pittaluga S, et al. N Engl J Med 2025;392:1760-1762.

Read + Share

Amedeo Smart

Independent Medical Education

Prica A, Roschewski M, Beale P, Pittaluga S, et al. Glofitamab with Polatuzumab Vedotin in Refractory Burkitt's Lymphoma. N Engl J Med 2025;392:1760-1762.
PMID: 40305722